Loading...

Ligand Pharmaceuticals, Inc.

LGNZZ•PNK
Healthcare
Medical - Pharmaceuticals
$0.08
$0.005(6.67%)
U.S. Market opens in 50h 29m

Ligand Pharmaceuticals, Inc. (LGNZZ) Stock Overview

Explore Ligand Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.6M
P/E Ratio0.01
EPS (TTM)N/A
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$0.05
3 Months$0.05
1 Year Target$0.09

LGNZZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ligand Pharmaceuticals, Inc. (LGNZZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.01 and a market capitalization of 1.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
6.67%
5-Day Change
N/A
1-Month Change
9.59%
3-Month Change
14.29%
6-Month Change
8.11%
Year-to-Date (YTD) Change
11.11%
1-Year Change
-42.45%
3-Year Change
-33.43%
5-Year Change
-42.86%
All-Time (Max) Change
-98.80%

Contact Information

https://www.ligand.com
+1 858 550 7500
555 Heritage Drive, Jupiter, NaN, NaN

Company Facts

680 Employees
IPO DateJun 16, 2004
CountryUS
Actively Trading

Frequently Asked Questions